Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen C Mack

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Cancer Discovery|August 29, 2019
Targeting Glioblastoma Stem Cells through Disruption of the Circadian ClockZhen Dong, Guoxin Zhang, Meng Qu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2025
B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune ResponseSanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, et al.
Nature Communications|February 8, 2017
Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenomeAndrea J Cohen, Alina Saiakhova, Olivia Corradin, et al.
Nature|July 31, 2024
Histone serotonylation regulates ependymoma tumorigenesisHsiao-Chi Chen, Peihao He, Malcolm McDonald, et al.
Cell|November 26, 2019
Functional Enhancers Shape Extrachromosomal Oncogene AmplificationsAndrew R Morton, Nergiz Dogan-Artun, Zachary J Faber, et al.
Cancer Research|July 22, 2017
MYC-Regulated Mevalonate Metabolism Maintains Brain Tumor-Initiating CellsXiuxing Wang, Zhi Huang, Qiulian Wu, et al.
Science Translational Medicine|August 9, 2019
Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cellsXiuxing Wang, Kailin Yang, Qiulian Wu, et al.
Nature Neuroscience|March 28, 2017
Purine synthesis promotes maintenance of brain tumor initiating cells in gliomaXiuxing Wang, Kailin Yang, Qi Xie, et al.
Acta Neuropathologica|August 15, 2014
Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cellsMark Barszczyk, Pawel Buczkowicz, Pedro Castelo-Branco, et al.
Cancer Discovery|March 20, 2021
<i>ZFTA</i> Translocations Constitute Ependymoma Chromatin Remodeling and Transcription FactorsRobert Kupp, Lisa Ruff, Sabrina Terranova, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Cancer Discovery|August 29, 2019
Targeting Glioblastoma Stem Cells through Disruption of the Circadian ClockZhen Dong, Guoxin Zhang, Meng Qu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2025
B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune ResponseSanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, et al.
Nature Communications|February 8, 2017
Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenomeAndrea J Cohen, Alina Saiakhova, Olivia Corradin, et al.
Nature|July 31, 2024
Histone serotonylation regulates ependymoma tumorigenesisHsiao-Chi Chen, Peihao He, Malcolm McDonald, et al.
Cell|November 26, 2019
Functional Enhancers Shape Extrachromosomal Oncogene AmplificationsAndrew R Morton, Nergiz Dogan-Artun, Zachary J Faber, et al.
Cancer Research|July 22, 2017
MYC-Regulated Mevalonate Metabolism Maintains Brain Tumor-Initiating CellsXiuxing Wang, Zhi Huang, Qiulian Wu, et al.
Science Translational Medicine|August 9, 2019
Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cellsXiuxing Wang, Kailin Yang, Qiulian Wu, et al.
Nature Neuroscience|March 28, 2017
Purine synthesis promotes maintenance of brain tumor initiating cells in gliomaXiuxing Wang, Kailin Yang, Qi Xie, et al.
Acta Neuropathologica|August 15, 2014
Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cellsMark Barszczyk, Pawel Buczkowicz, Pedro Castelo-Branco, et al.
Cancer Discovery|March 20, 2021
<i>ZFTA</i> Translocations Constitute Ependymoma Chromatin Remodeling and Transcription FactorsRobert Kupp, Lisa Ruff, Sabrina Terranova, et al.
Pageof 10